| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.006 |